Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
November 09, 2020 07:00 ET
|
Congencia
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications...
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
November 09, 2020 02:00 ET
|
Congencia
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform New Funds to Drive Further Commercialisation of Rare and Inherited Cancer...
Kura Oncology Reports Third Quarter 2020 Financial Results
November 05, 2020 07:30 ET
|
Kura Oncology, Inc.
– Preliminary data from first-in-human trial of menin inhibitor KO-539 accepted for oral presentation at ASH – – Encouraging safety, tolerability and activity with KO-539 highlighted in ASH abstract...
Global Cell Therapy Market and Technology Forecast 2020-2028
November 03, 2020 13:08 ET
|
Research and Markets
Dublin, Nov. 03, 2020 (GLOBE NEWSWIRE) -- The "Global Cell Therapy - Market and Technology Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global revenue of the...
Progenity to Report Third Quarter 2020 Financial Results and Provide Corporate Update
November 03, 2020 08:43 ET
|
Progenity, Inc.
SAN DIEGO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Announces Successful Achievement of its Preeclampsia Test Analytical Verification Milestone
October 29, 2020 07:30 ET
|
Progenity, Inc.
Announces Expansion of its COVID-19 Testing Offering Provides Preliminary Third Quarter 2020 Financial Update SAN DIEGO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a...
Kura Oncology to Report Third Quarter 2020 Financial Results
October 29, 2020 07:30 ET
|
Kura Oncology, Inc.
SAN DIEGO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of...
Progenity Presents Data from Award-Winning Abstract on Novel Ingestible Lab-in-a-Capsule at American College of Gastroenterology (ACG) 2020 Virtual Annual Meeting
October 27, 2020 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Kura Oncology Reports Preclinical Results Showing Antitumor Activity of Tipifarnib in Combination with PI3Kα Inhibitor in Head and Neck Squamous Cell Carcinoma
October 26, 2020 07:30 ET
|
Kura Oncology, Inc.
– Preclinical data support potential to expand therapeutic utility of tipifarnib to HRAS/PI3K dependent tumors representing up to 50% of HNSCC – – Company plans to conduct a Phase 1/2...
Philips showcases integrated radiation oncology solutions to streamline diagnosis and treatment at ASTRO 2020
October 22, 2020 09:00 ET
|
Royal Philips
October 22, 2020 Radiation Oncology Orchestrator (IntelliSpace Radiation Oncology) and Practice Management [1] can reduce the time from patient referral to the start of treatment by up to half ...